Let’s all be honest about hydroxychloroquine: Evidence is more positive than many in the medical community admit
valuable early outpatient therapy could be for millions of vulnerable adults in this country and around the world. Hydroxychloroquine may also play a role in reducing the risk faced by adults who are unwilling or unable to receive a COVID-19 vaccine.